CIK: 0001728001
申报总市值
US$86.9亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | 股票-其他 | 77.33% | — | +40.29% | |
| 2 | PTCT 3 08-15-22 | Ptc Therapeutics INC | 股票-医疗保健 | 21.23% | — | -17.81% | |
| 3 | HQ8F | Apollo Endosurgery INC | 股票-其他 | 1.44% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | +9.7% | +40.29% | 加仓 |
| 2 | HQ8F | Apollo Endosurgery INC | -0.5% | — | 不变 |
| 3 | PTCT 3 08-15-22 | Ptc Therapeutics INC | -9.2% | -17.81% | 减仓 |